Full Text
Regulatory Approval for Oncology Products In Brazil- A Comparison Between The Fda And Anvisa Approval Timelines

Abstract

Authors

M Martin de Bustamante S Duttagupta R Beckerman NJ Smith F Roitberg G Lopes

Back to Volume 18, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×